We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$72.4B
AUM Growth
+$3.34B
Cap. Flow
+$3.15B
Cap. Flow %
4.35%
Top 10 Hldgs %
24.2%
Holding
3,853
New
175
Increased
1,612
Reduced
1,555
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Financials 13.44%
3 Consumer Discretionary 11.14%
4 Healthcare 9.82%
5 Communication Services 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHX icon
3651
Marchex
MCHX
$79.3M
-40,900
Closed -$76.5K
MCRB icon
3652
Seres Therapeutics
MCRB
$50.2M
-915
Closed -$17.3K
MIR icon
3653
Mirion Technologies
MIR
$3.75B
-163,766
Closed -$1.81M
MYGN icon
3654
Myriad Genetics
MYGN
$311M
-3,954
Closed -$108K
NAUT icon
3655
Nautilus Biotechnolgy
NAUT
$110M
-167
Closed -$476
NERV icon
3656
Minerva Neurosciences
NERV
$215M
-1,175
Closed -$3.14K
NTIC icon
3657
Northern Technologies International Corp
NTIC
$77M
-26
Closed -$320
OCGN icon
3658
Ocugen
OCGN
$444M
-3,176
Closed -$3.15K
OM icon
3659
Outset Medical
OM
$91.4M
-633
Closed -$6.43K
OPAD icon
3660
Offerpad Solutions
OPAD
$22.9M
-4
Closed -$171
OPFI icon
3661
OppFi
OPFI
$749M
-1,920
Closed -$9.08K
OPI
3662
DELISTED
Office Properties Income Trust
OPI
-12,686
Closed -$27.7K
OPTN
3663
DELISTED
OptiNose
OPTN
-382
Closed -$3.84K
PHAT icon
3664
Phathom Pharmaceuticals
PHAT
$693M
-36
Closed -$651
PRLD icon
3665
Prelude Therapeutics
PRLD
$385M
-76
Closed -$157
PRM icon
3666
Perimeter Solutions
PRM
$5.65B
-237
Closed -$3.19K
PRTH icon
3667
Priority Technology Holdings
PRTH
$431M
-128
Closed -$874
PWB icon
3668
Invesco Large Cap Growth ETF
PWB
$2.39B
-21
Closed -$2.07K
RDZN icon
3669
Roadzen
RDZN
$108M
-2,638
Closed -$3.14K
REM icon
3670
iShares Mortgage Real Estate ETF
REM
$538M
-288,550
Closed -$6.85M
RGNX icon
3671
Regenxbio
RGNX
$688M
-28,281
Closed -$297K
RLYB icon
3672
Rallybio
RLYB
$88.2M
-131
Closed -$1.23K
SACH
3673
Sachem Capital Corp
SACH
$38.6M
-108
Closed -$273
SCPH
3674
DELISTED
scPharmaceuticals
SCPH
-449
Closed -$2.05K
SLI
3675
Standard Lithium
SLI
$623M
-5
Closed -$8

Similar funds

Russell Investments Group's Q4 2024 Portfolio in Review

As of Q4 2024, Russell Investments Group held 3,853 positions worth $72.4B, up 4.8% from $69.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Russell Investments Group deployed $3.15B of net new capital in Q4 2024, opening 175 new positions and adding to 1,612 existing holdings. Its largest new stake was Ares Management Corp 6.75% Series B Preferred Stock: 2,440,950 shares worth $2.69M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apollo Global Management Series A, an estimated $110M trimmed.

  • Russell Investments Group's largest Q4 2024 buy was Ares Management Corp 6.75% Series B Preferred Stock: 2,440,950 shares worth $2.69M.
  • Russell Investments Group added most to NVIDIA in Q4 2024, an estimated $402M increase.
  • Russell Investments Group's biggest Q4 2024 reduction was Apollo Global Management Series A, cutting an estimated $110M.
  • Russell Investments Group fully exited Primo Water Corporation in Q4 2024, selling an estimated $23M.
  • Russell Investments Group's ten largest holdings make up 24% of its $72.4B portfolio in Q4 2024.
  • Russell Investments Group opened 175 new positions and closed 162 in Q4 2024.
  • Russell Investments Group's portfolio value rose 4.8% quarter-over-quarter to $72.4B.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.